Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Advanced Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02516813
What this trial is testing

Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy

Who this might be right for
Advanced Solid Tumors
EMD Serono Research & Development Institute, Inc. 52
Testing effectiveness (Phase 2)WithdrawnNCT06090318
What this trial is testing

Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss

Who this might be right for
Advanced Solid TumorCDKN2ANSCLC+7 more
Rain Oncology Inc
Testing effectiveness (Phase 2)Looking for participantsNCT06515990
What this trial is testing

DM005 in Patients With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungSquamous Cell Carcinoma of Head and NeckSolid Carcinoma
Doma Biopharmaceutical（Suzhou）Co., Ltd. 208
Early research (Phase 1)Temporarily pausedNCT05076591
What this trial is testing

IMM2902, a HER2/SIRPα Bispecific MAb-Trap Antibody-receptor Fusion Protein, in Patients with HER2-expressing Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced Breast CancerAdvanced Gastric Cancer
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 135
Early research (Phase 1)Study completedNCT00669097
What this trial is testing

Absorption, Distribution, Metabolism and Excretion (ADME) Study of TKI258 in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
Novartis Pharmaceuticals 13
Early research (Phase 1)Study completedNCT01404390
What this trial is testing

Japanese BAY80-6946 Monotherapy Phase I Study

Who this might be right for
Neoplasms
Bayer 10
Early research (Phase 1)UnknownNCT01337310
What this trial is testing

Study of Tesetaxel in Japanese Patients With Solid Tumors

Who this might be right for
Advanced Solid Tumors
Genta Incorporated 12
Early research (Phase 1)Study completedNCT00412997
What this trial is testing

LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma

Who this might be right for
TumorsCutaneous T-Cell Lymphoma
Novartis 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793318
What this trial is testing

TR115 in ARID1A-Mutated Advanced Solid Tumors

Who this might be right for
Ovarian Clear Cell CarcinomaEndometrial CancerStomach Cancer Recurrent+1 more
Tarapeutics Science Inc. 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06220318
What this trial is testing

Assessment of the Safety and Efficacy of C019199 Plus Sintilimab in Participants With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Fujian Haixi Pharmaceuticals Co., Ltd. 155
Early research (Phase 1)Study completedNCT01170897
What this trial is testing

Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Halozyme Therapeutics 27
Early research (Phase 1)Study completedNCT04808453
What this trial is testing

Phase I Study of CPI-300 in Patients With Advanced Tumors

Who this might be right for
Advanced Tumors
Coordination Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Looking for participantsNCT07296341
What this trial is testing

HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Pancreatic Cancer With
Shanghai Hengrui Pharmaceutical Co., Ltd. 60
Early research (Phase 1)Ended earlyNCT06540066
What this trial is testing

BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced CancerAdvanced Solid TumorMetastatic Cancer+1 more
BeiGene 35
Early research (Phase 1)Looking for participantsNCT06686745
What this trial is testing

Study of SIM0508 Alone and in Combination in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd. 130
Testing effectiveness (Phase 2)Looking for participantsNCT06293651
What this trial is testing

Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Dong-A ST Co., Ltd. 125
Early research (Phase 1)Study completedNCT05277402
What this trial is testing

ADG116 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced/Metastatic Solid Tumors
Adagene Inc 6
Testing effectiveness (Phase 2)Ended earlyNCT05169437
What this trial is testing

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

Who this might be right for
Solid TumorBreast TumorColon Tumor, Malignant+9 more
Tempus AI 22
Not applicableUnknownNCT05649163
What this trial is testing

Real-world Study of HER2-overexpressed Advanced Solid Tumors After Progression of First-line Standard Therapy

Who this might be right for
HER2Advanced Gastric CancerAdvanced Gastroesophageal Junction Adenocarcinoma+1 more
Shen Lin 306
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06992687
What this trial is testing

Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Shanghai Huaota Biopharmaceutical Co., Ltd. 30
Next Page